Abstract
Extracellular vesicles (EVs) are released from various cell types and play an important role in intercellular interactions. In our study, we investigated abundance of individual EVs in patients with acute forms of ischemic heart disease. Previously, we developed an approach for individual analysis of EVs conjugated with magnetic nanoparticles (MNPs), which was applied in the current study for analyzing phenotypic composition of EVs (by staining for markers CD31, CD41a, and CD63). EVs were isolated using fluorescently labeled MNPs containing anti-CD31, CD41a, or CD63 antibodies and analyzed by combining fluorescently labeled anti-CD41a and CD63, CD31 and CD63, or CD41a and CD31 antibodies, respectively. EVs were analyzed in 30 individuals: 17 healthy volunteers and 13 patients with acute coronary syndrome (ACS). Six and seven ACS patients were with acute myocardial infarction and unstable angina, respectively. It was found that patients with ACS and healthy volunteers contained a dominant subset of EVs expressing surface CD41a antigen, suggesting that they originated from platelets. In addition, the total number of EVs isolated using either of the surface markers examined in our study was higher in patients with ACS compared to healthy volunteers. The subgroup of patients with acute myocardial infarction was found to contain significantly higher number of blood EVs compared to the control group. Moreover, increased number of EVs in patients with ACS is mainly due to the increased number of EVs in the subset of EVs bearing CD41a. By analyzing individual EVs, we found that plasma of patients with ACS, particularly upon developing of myocardial infarction, contained dominant platelet-derived EVs fraction, which may reflect activation of platelets in such patients.
Similar content being viewed by others
References
Ong, S.-G., Lee, W. H., Huang, M., Dey, D., Kodo, K., Sanchez-Freire, V., Gold, J. D., and Wu, J. C. (2014) Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer, Circulation, 130, S60–S69.
Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., and Mi, S. (2015) Exosome and exosomal microRNA: trafficking, sorting, and function, Genom. Proteom. Bioinform., 13, 17–24.
Yuana, Y., Sturk, A., and Nieuwland, R. (2013) Extracellular vesicles in physiological and pathological conditions, Blood Rev., 27, 31–39.
Record, M., Carayon, K., Poirot, M., and Silvente-Poirot, S. (2014) Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies, Biochim. Biophys. Acta, 1841, 108–120.
Rautou, P. E., Vion, A. C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., and Boulanger, C. M. (2011) Microparticles, vascular function, and atherothrombosis, Circ. Res., 109, 593–606.
Ayers, L., Harrison, P., Kohler, M., and Ferry, B. (2014) Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity, J. Extracell. Vesicles, doi: 10.3402/jev.v3.25348.
Lacroix, R., Dubois, C., Leroyer, A. S., Sabatier, F., and Dignat-George, F. (2013) Revisited role of microparticles in arterial and venous thrombosis, J. Thromb. Haemost., 11 (Suppl. 1), 24–35.
Leroyer, A. S., Tedgui, A., and Boulanger, C. M. (2008) Role of microparticles in atherothrombosis, J. Intern. Med., 263, 528–537.
Nomura, S., and Shimizu, M. (2015) Clinical significance of procoagulant microparticles, J. Intens. Care, 3, 2.
De Toro, J., Herschlik, L., Waldner, C., and Mongini, C. (2015) Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications, Front. Immunol., 6, 203.
Zocco, D., Ferruzzi, P., Cappello, F., Kuo, W. P., and Fais, S. (2014) Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs, Front. Oncol., 4, 267.
Colombo, M., Moita, C., Van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Thery, C., and Raposo, G. (2013) Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles, J. Cell Sci., 126, 5553–5565.
Besancenot, R., Chaligne, R., Tonetti, C., Pasquier, F., Marty, C., Lecluse, Y., Vainchenker, W., Constantinescu, S. N., and Giraudier, S. (2010) A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation, PLoS Biol., 8.
Aatonen, M. T., Ohman, T., Nyman, T. A., Laitinen, S., Gronholm, M., and Siljander, P. R. (2014) Isolation and characterization of platelet-derived extracellular vesicles, J. Extracell. Vesicles, 3, 1–15.
Amabile, N., Cheng, S., Renard, J. M., Larson, M. G., Ghorbani, A., Mc Cabe, E., Griffin, G., Guerin, C., Ho, J. E., Shaw, S. Y., Cohen, K. S., Vasan, R. S., Tedgui, A., Boulanger, C. M., and Wang, T. J. (2014) Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study, Eur. Heart J., 1-8.
Li, P., and Qin, C. (2015) Elevated circulating VE-cadherin+ CD144+ endothelial microparticles in ischemic cerebrovascular disease, Thromb. Res., 135, 375–381.
Hu, S.-S., Zhang, H.-G., Zhang, Q.-J., and Xiu, R.-J. (2014) Small-size circulating endothelial microparticles in coronary artery disease, PLoS One, 9, e104528.
Jung, C., Sorensson, P., Saleh, N., Arheden, H., Ryden, L., and Pernow, J. (2012) Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction, Atherosclerosis, 221, 226–231.
Gyorgy, B., Szabo, T. G., Pasztoi, M., Pal, Z., Misjak, P., Aradi, B., Laszlo, V., Pallinger, E., Pap, E., Kittel, A., Nagy, G., Falus, A., and Buzas, E. I. (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles, Cell. Mol. Life Sci., 68, 2667–2688.
Stepien, E., Stankiewicz, E., Zalewski, J., Godlewski, J., Zmudka, K., and Wybranska, I. (2012) Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation, Arch. Med. Res., 43, 31–35.
Skeppholm, M., Mobarrez, F., Malmqvist, K., and Wallen, H. (2012) Platelet-derived microparticles during and after acute coronary syndrome, Thromb. Haemost., 107, 1122–1129.
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., (2012) Third universal definition of myocardial infarction, J. Am. Coll. Cardiol., 60, 1581–1598.
Van der Pol, E., Coumans, F. A. W., Grootemaat, A. E., Gardiner, C., Sargent, I. L., Harrison, P., Sturk, A., Van Leeuwen, T. G., and Nieuwland, R. (2014) Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing, J. Thromb. Haemost., 12, 1182–1192.
Witwer, K. W., Buzas, E. I., Bemis, L. T., Bora, A., Lasser, C., Lotvall, J., Nolte’t-Hoen, E. N., Piper, M. G., Sivaraman, S., Skog, J., Thery, C., Wauben, M. H., and Hochberg, F. (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research, J. Extracell. Vesicles, 2.
Steg, P. G., James, S. K., Atar, D., Badano, L. P., Blomstrom-Lundqvist, C., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A. H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M. J., Mahaffey, K. W., Valgimigli, M., Van’t Hof, A., Widimsky, P., and Zahger, D. (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur. Heart J., 33, 2569–2619.
Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., Ohman, M., Petrie, M. C., Sonntag, F., Uva, M. S., Storey, R. F., Wijns, W., and Zahger, D. (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio, Eur. Heart J., 32, 2999–3054.
Arakelyan, A., Ivanova, O., Vasilieva, E., Grivel, J.-C., and Margolis, L. (2015) Antigenic composition of single nanosized extracellular blood vesicles, Nanomedicine, 11, 489–498.
Arakelyan, A., Fitzgerald, W., Margolis, L., and Grivel, J. (2013) Nanoparticle-based flow virometry for the analysis of individual virions, J. Clin. Invest., 123, 3716–3727.
Campbell, E. C., Antoniou, A. N., and Powis, S. J. (2012) The multi-faceted nature of HLA class I dimer molecules, Immunology, 136, 380–384.
Andre, F., Chaput, N., Schartz, N. E. C., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D.-H., Tursz, T., Amigorena, S., Angevin, E., and Zitvogel, L. (2004) Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells, J. Immunol., 172, 2126–2136.
Lynch, S., Santos, S. G., Campbell, E. C., Nimmo, A. M. S., Botting, C., Prescott, A., Antoniou, A. N., and Powis, S. J. (2009) Novel MHC class I structures on exosomes, J. Immunol., 183, 1884–1891.
Thery, C. (2011) Exosomes: secreted vesicles and intercellular communications, F1000 Biol. Rep., 3, 15.
Biasucci, L. M., Porto, I., Di Vito, L., De Maria, G. L., Leone, A. M., Tinelli, G., Tritarelli, A., Di Rocco, G., Snider, F., Capogrossi, M. C., and Crea, F. (2012) Differences in microparticle release in patients with acute coronary syndrome and stable angina, Circ. J., 76, 2174–2182.
Kafian, S., Mobarrez, F., Wallen, H., and Samad, B. (2014) Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome, Platelets, 7104, 1–7.
Morel, O., Pereira, B., Averous, G., Faure, A., Jesel, L., Germain, P., Grunebaum, L., Ohlmann, P., Freyssinet, J. M., Bareiss, P., and Toti, F. (2009) Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation, Atherosclerosis, 204, 636–641.
Lovren, F., and Verma, S. (2013) Evolving role of microparticles in the pathophysiology of endothelial dysfunction, Clin. Chem., 59, 1166–1174.
Helbing, T. (2014) Role of microparticles in endothelial dysfunction and arterial hypertension, World J. Cardiol., 6, 1135.
Bobrie, A., Colombo, M., Krumeich, S., Raposo, G., and Thery, C. (2012) Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation, J. Extracell. Vesicles, 1, 1–11.
Metzelaar, M. J., Wijngaard, P. L. J., Peters, P. J., Sixma, J. J., Nieuwenhuis, H. K., and Clevers, H. C. (1991) CD63 antigen: a novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells, J. Biol. Chem., 266, 3239–3245.
Piccin, A., Murphy, W. G., and Smith, O. P. (2007) Circulating microparticles: pathophysiology and clinical implications, Blood Rev., 21, 157–171.
Antwi-Baffour, S., Adjei, J., Aryeh, C., Kyeremeh, R., Kyei, F., and Seidu, M. A. (2015) Understanding the biosynthesis of platelets-derived extracellular vesicles, Immun. Inflamm. Dis., 3, 133–140.
Min, P.-K., Kim, J.-Y., Chung, K.-H., Lee, B. K., Cho, M., Lee, D.-L., Hong, S.-Y., Choi, E.-Y., Yoon, Y.-W., Hong, B.-K., Rim, S.-J., and Kwon, H. M. (2013) Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction, Atherosclerosis, 227, 323–328.
Patrono, C., and Renda, G. (1997) Platelet activation and inhibition in unstable coronary syndromes, Am. J. Cardiol., 80, 17–20.
Harker, L. A., and Ritchie, J. L. (1980) The role of platelets in acute vascular events, Circulation, 62, 13–18.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M. S. Vagida, A. Arakelyan, A. M. Lebedeva, J.-Ch. Grivel, A. V. Shpektor, E. Yu. Vasilieva, L. B. Margolis, 2016, published in Biokhimiya, 2016, Vol. 81, No. 4, pp. 527-537.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM15-312, February 7, 2016.
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Vagida, M.S., Arakelyan, A., Lebedeva, A.M. et al. Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome. Biochemistry Moscow 81, 382–391 (2016). https://doi.org/10.1134/S0006297916040088
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297916040088